Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.

Johnson & Johnson Robotics and Digital Solutions

MedVest Fund II

Medvest Capital

Johnson & Johnson Development Corporation

HM Capital

Huimei Capital

Prism Venture Management

Asteroid Partners

Gideon Strategic Partners

GOS Capital

Osteal Therapeutics

Osteal Therapeutics’ VT-X7 Receives FDA’s Breakthrough Therapy Designation for the treatment of periprosthetic joint infection of the hip and knee and completes enrollment of the pivotal APEX-2 trial.
https://bit.ly/3Gqtl1n


Osteal Therapeutics is proud to be named as a 2023 Rising Star by Bio North Texas! 

Osteal Therapeutics Closes Over Subscribed Series C Financing. We're able to focus on lifting the burden of periprosthetic joint infection because of the tremendous support from our existing and new investors. Their enthusiasm is validating and energizing. 

https://bit.ly/45ZVF5A

Our President & CEO, David Thompson, is presenting at #LSIEurope23 in Barcelona this week. 

If you're attending, make sure you listen to his talk about the amazing journey Osteal Therapeutics is on to lift the burden of periprosthetic joint infection. 

#LSIAlumni #medtech

Horizon Therapeutics is a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases.

Horizon Therapeutics

Ensoma is a biotechnology company specializing in gene therapy and genetic medicines to treat a wide range of diseases, including rare genetic disorders.

Ensoma

Avita Medical is a regenerative medicine company that develops and distributes regenerative products for the treatment of a broad range of wounds, scars, and skin defects.

Avita Medical

Histogenics is a biotechnology company focused on developing and commercializing regenerative medicine products for the musculoskeletal system, particularly for cartilage repair.

Histogenics

ZetaGen is a biotechnology company that focuses on developing advanced therapies using genetic engineering and stem cell technologies for various medical applications.

ZetaGen

Organogenesis is a leading regenerative medicine company that develops and commercializes solutions for the advanced wound care, surgical, and sports medicine markets.

Organogenesis

ARTHEx is a biotechnology company focused on developing innovative therapies for orthopedic and musculoskeletal conditions, with a particular emphasis on bone tissue engineering.

ARTHEx

Stayble Therapeutics is a biotechnology company specializing in the development of novel treatments for spinal disc-related disorders and chronic lower back pain.

Stayble Therapeutics

Osteal Therapeutics is a biotechnology company focused on developing advanced regenerative medicine therapies to treat a variety of conditions, particularly those related to bone and cartilage. Their approach involves the use of stem cell-based therapies to repair and regenerate damaged tissues.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 16, 2024 7:53 AM	3c390219
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 16, 2024 7:53 AM	4129e7c8
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:OSTEALTX

Osteal Therapeutics